Mechanical Thrombectomy in Two Children Under the Age of One Year

Erensu Mengüşoğlu1, Francesco Puccinelli2, Steven D Hajdu2

  • 1Department of Neurology Kartal Lütfi Kırdar City Hospital Istanbul Turkey.

Clinical Case Reports
|October 17, 2025
PubMed

Insights

Mechanical thrombectomy (MT) is a viable treatment for infants experiencing stroke complications during retinoblastoma treatment. This study shows MT is safe and effective, achieving full artery reopening and normal neurological outcomes in two young patients.

Area of Science:

  • Pediatric Neurology
  • Interventional Neuroradiology
  • Ophthalmology

Background:

  • Mechanical thrombectomy (MT) is rarely performed in infants due to limited data and ethical considerations.
  • Thromboembolic complications can occur during intra-arterial chemotherapy for retinoblastoma in infants.
  • Infantile stroke presents unique challenges for treatment and management.

Purpose of the Study:

  • To evaluate the feasibility and safety of mechanical thrombectomy (MT) with thromboaspiration in infants.
  • To assess the outcomes of MT in two infants experiencing thromboembolic events during retinoblastoma treatment.
  • To contribute to the limited data on MT in pediatric stroke management.

Main Methods:

  • Case series review of two infants under one year old undergoing mechanical thrombectomy.
  • Procedure involved thromboaspiration for arterial occlusion.
  • Outcomes assessed via recanalization (eTICI score), infarction/hemorrhage on imaging, and neurological status (pedNIHSS).

Main Results:

  • Successful full recanalization (eTICI=3) was achieved in both infant cases.
  • No instances of infarction or hemorrhage were observed post-procedure.
  • Both patients demonstrated normal neurological outcomes (pedNIHSS=0) with no complications.

Conclusions:

  • Mechanical thrombectomy (MT) is a feasible and safe intervention for infants with arterial occlusions.
  • MT can lead to excellent neurological outcomes in high-risk pediatric cases.
  • Further research is warranted to develop standardized guidelines for MT in pediatric stroke.